United Kingdom· GB-APID-22112211000001104
Vyndaqel 20mg capsules
A tafamidis product containing tafamidis, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Tafamidis is registered in 17 of 19 countries.
Countries holding a registration under ATC N07XX08 (tafamidis), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Tafamidis · ATC N07XX08
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tafamidis costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.082 in France to $118.78 in Switzerland — a ×1457 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tafamidis · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$118.78
- FR France$0.082
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Tafamidis
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- N07XX08
- ATC class
- Tafamidis
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5013457015027
- gtin5415062348178
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
18 interactions on record for tafamidis.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tafamidis · interactions on record
18 records
- 2 severe
- 16 moderate
Most severe, free to view
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- EltrombopagB02BX05moderate
- LusutrombopagB02BX07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tafamidis in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsVyndaqel 20 mg zachte capsulesPfizer Europe MA EEIG
- SpainTAFAMIDIS ACCORD 61 MG CAPSULAS BLANDAS EFGAccord Healthcare S.L.U.
- SwedenTafamidis STADA Nordic 61 mg Kapsel, mjukSTADA Nordic ApS
- BelgiumTafamidis EG 61 mgEG
- CzechiaVYNDAQELPfizer Europe MA EEIG, Bruxelles
- IrelandVyndaqel 61 mg soft capsulesPfizer Europe MA EEIG
- SwitzerlandVyndaqel 20 mg, WeichkapselnPfizer AG
- FinlandVyndaqelPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Tafamidis Stada, Tafamidis Viatris
- Belgium · Tafamidis Viatris
- Germany · Tafamidis Al, Tafamidis Viatris
- Spain · Tafamidis Stada, Tafamidis Viatris
- France · Tafamidis Biogaran, Tafamidis Eg
- Iceland · Vyndaqel
- Liechtenstein · Vyndaqel
- Norway · Tafamidis Stada Nordic, Tafamidis Viatris
- Sweden · Tafamidis Stada Nordic, Tafamidis Viatris
- Slovenia · Tafamidis Sumar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8155b8b4-4801-45f4-9b5f-dbab94bf84b7 GET /v1/drugs/8155b8b4-4801-45f4-9b5f-dbab94bf84b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "22112211000001104",
"desc": "Vyndaqel 20mg capsules (Pfizer Ltd)",
"form": "Oral capsule",
"vpid": "22155011000001108",
"source": "dmd",
"vtm_id": "777665007",
"strength": "20 mg",
"substance": "Tafamidis",
"ingredient": "Tafamidis meglumine",
"supplier_code": "2082201000001106"
}See everything about tafamidis.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.